Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore
Status:
Withdrawn
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
Given the high prevalence of COVID19 illness (both SARS-CoV-2 RT-PCR confirmed and highly
suspect cases) among healthcare workers (HCW) within the Montefiore Health System (MHS),
hydroxychloroquine (HCQ) will be prescribed to healthcare workers who are at the highest risk
for severe COVID19 illness.